Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1990
12/19/1990EP0402354A1 Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine
12/19/1990CN1047884A Hepatitis a attenuation living vaccine (h2 attenuation strains) and preparation thereof
12/19/1990CA2019217A1 Magnetic protein conjugates, a process for the preparation thereof and the use thereof
12/18/1990US4978745 Immunoreactive heterochain antibodies
12/18/1990US4978622 Cytophaga-derived immunopotentiator
12/18/1990US4978621 Merozoite surface antigens
12/18/1990US4978609 Monoclonal antibody specific to human pancreatic phospholipase A2
12/18/1990US4978520 Injecting antibodies, biofiltration, recovering filtered antibodies
12/18/1990CA1277934C Hybrid cells producing an antibody characteristic of the hepatitis b virus from hepatocytes and established cells of monkey, process for obtaining such hybrid cells and application thereof for the production of the antigens aforementioned
12/17/1990WO1990015808A1 Radionuclide metal chelates for the radiolabeling of proteins
12/16/1990WO1990015878A1 Immunoactive peptides and antibodies and their use in anti-allergy treatment
12/16/1990WO1990015870A1 Interleukin-7 receptors
12/16/1990WO1990015596A1 Glucan drug delivery system and adjuvant
12/16/1990CA2059275A1 Glucan drug delivery system and adjuvant
12/16/1990CA2033082A1 Interleukin-7 receptors
12/15/1990WO1990015622A1 Method of preparing vaccines against rna viruses
12/14/1990WO1990015820A1 Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection
12/14/1990CA2062713A1 Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection
12/13/1990WO1990015158A1 Nucleotide sequences for the amplification of the hiv-2 and siv type retrovirus genome, and their applications in in vitro diagnosis of infections caused by these viruses
12/13/1990WO1990015152A1 Monoclonal antibodies for inducing tolerance
12/13/1990WO1990015141A2 Self-assembled, defective, non-self-propagating viral particles
12/13/1990WO1990015133A1 Method of producing core structure of retro virus and particle produced thereby
12/13/1990WO1990015132A2 Cloned treponema hyodysenteriae endoflagellar antigen
12/13/1990WO1990015077A1 Monoclonal antibody specific for bacterial transport proteins, and antibody-containing deodorant composition
12/13/1990WO1990015075A1 HTLV-1 ENV GENE PRODUCTS EXPRESSED IN $i(E. COLI)
12/13/1990WO1990015074A1 Methods for enhancing the rate of modification of metastable bonds
12/13/1990WO1990015066A2 Nucleotidic sequences resulting from the retrovirus gemone of the hiv-1, hiv-2, and siv type, and their applications, in particular for the amplification of the genomes of said retroviruses and for the in vitro diagnosis of infections caused by these viruses
12/13/1990WO1990014881A2 Chelating agents for attaching metal ions to proteins
12/13/1990WO1990014837A1 Adjuvant formulation comprising a submicron oil droplet emulsion
12/13/1990CA2685262A1 Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses
12/13/1990CA2033086A1 Chelating agents for attaching metal ions to proteins
12/12/1990EP0402116A1 Proteins, vaccines and nucleic acids
12/12/1990EP0402088A2 Conjugate immunogen for aids
12/12/1990EP0401941A2 Hepatitis B virus surface antigen and production thereof
12/12/1990EP0401421A2 Non-reverting RNA viruses
12/12/1990EP0401347A1 Use of transferrin to combat the toxic effects of endotoxins in endotoxemia.
12/12/1990EP0401248A1 Affinity matrices of modified polysaccharide supports
12/12/1990EP0401247A1 Monoclonal antibody specific to a novel mucin-like glycoprotein surface antigen on human carcinoma cells
12/11/1990US4977092 Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells
12/11/1990US4976958 Mycobacterial recombinants and peptides
12/11/1990US4976957 Process for the production of recognins and their chemoreciprocals
12/11/1990CA1277614C Sialylated lewisx epitope, antibodies and diagnosis
12/11/1990CA1277613C Monoclonal antibodies, a process for their preparation and their use
12/11/1990CA1277612C Monoclonal antibodies with specificity for membrane- associated antigens
12/11/1990CA1277600C Tumor therapeutic agent and a process for its preparation
12/08/1990CA2018453A1 Methods for enhancing the rate of modification of metastable bonds
12/07/1990CA2018248A1 Monoclonal antibodies against the human alpha/beta t-cell receptor, their production and use
12/06/1990WO1990015078A1 HUMAN MONOCLONAL ANTIBODIES TO HIV-1MN gp 120
12/06/1990CA2058630A1 Human monoclonal antibodies to hiv-1 mn gp 120
12/06/1990CA2018332A1 Proteins, vaccines and nucleic acids
12/06/1990CA2018297A1 Conjugate immunogen for aids
12/05/1990EP0401055A2 Bone Calcification factor
12/05/1990EP0400973A1 Mycobacterial secretory expression vectors and transformants
12/05/1990EP0400958A2 Live vaccines
12/05/1990EP0400762A1 Treating animals using IL-2, formulations therefor and their preparation
12/05/1990EP0400569A2 Method for preparing a vaccine from Streptococcus mutans for dental caries and vaccinal compositions for dental caries used as nasal drops
12/05/1990EP0400464A1 Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment
12/05/1990EP0400107A1 Swine dysentery subunit vaccine and method
12/05/1990EP0400077A1 Use of synthetic peptides to generate and manipulate cellular immunity
12/05/1990EP0103605B1 Method for free ligand assays
12/05/1990CN1047531A Hog cholera virus vaccine and diagnostic
12/04/1990WO1990015073A1 Grf peptides
12/04/1990US4975420 Agents and procedures for provoking an immune response to GnRH and immuno sterilizing mammals
12/04/1990US4975369 Recombinant and chimeric KS1/4 antibodies directed against a human adenocarcinoma antigen
12/04/1990CA2055619A1 Grf peptides
12/04/1990CA1277270C Process for the culture of the infectious rhinotracheitis virus, particularlyof the turkey, and vaccine prepared with the virus thus obtained
12/04/1990CA1277262C Antibodies, manufacture and use
12/04/1990CA1277261C Monoclonal antibodies and hybridoma cells, to humain reinin: processes for their preparation and their applications
12/04/1990CA1277260C Monoclonal antibody panel for early diagnosis and therapy of renal carcinoma
12/04/1990CA1277231C Process and reagent for the specific determination of pancreatic -amylase
12/03/1990WO1990015875A1 Protein having a transactivating property, vectors expressing this protein, cell lines, and uses thereof
12/03/1990WO1990015149A1 Vpt protein, vectors expressing this protein, cell products and assay methods
12/03/1990WO1990015076A2 MONOCLONAL ANTIBODIES AGAINST LEUKOCYTE ADHESION RECEPTOR β-CHAIN, METHODS OF PRODUCING THESE ANTIBODIES AND USE THEREFORE
12/03/1990CA2056452A1 Protein having a transactivating property, vectors expressing this protein, cell lines, and uses thereof
12/03/1990CA2055591A1 Vpt protein, vectors expressing this protein, cell products and assay methods
12/02/1990CA2017466A1 Bone calcification factor
12/01/1990WO1990015140A1 Production of ibdv vp2 in highly immunogenic form
12/01/1990WO1990014842A1 Vaccine against hiv
12/01/1990WO1990014835A1 Method to treat rheumatoid arthritis
12/01/1990CA2056450A1 Method to treat rheumatoid arthritis
12/01/1990CA2055616A1 Vaccines
12/01/1990CA2050275A1 Production of ibdv vp2 in highly immunogenic form
12/01/1990CA2017936A1 Htlv-1 env gene products expressed in e. coli
12/01/1990CA2017528A1 Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment
11/1990
11/29/1990WO1990014436A1 Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus
11/29/1990WO1990014427A2 Multivalent repressor of gene function
11/29/1990WO1990014419A1 Human cell line lc5 and its use
11/29/1990WO1990014363A1 Metalloproteinase inhibitor
11/29/1990WO1990014357A1 Her2 extracellular domain
11/29/1990WO1990014351A1 Hematopoietic growth factor derived form t lymphocytes and methods of use therefor
11/29/1990WO1990014104A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
11/29/1990WO1990014099A2 Interleukin-2 tn treating birds
11/29/1990WO1990014073A1 Pharmaceutical preparation
11/29/1990CA2054764A1 Hematopoietic growth factor derived form t lymphocytes and methods of use therefor
11/28/1990EP0399843A2 Adjuvant formulation comprising a submicron oil droplet emulsion
11/28/1990EP0399777A2 Hematopoietic growth factor derived from T lymphocytes and methods of use therefor
11/28/1990EP0399257A1 Cell surface antigen that binds with L6 Monoclonal antibody
11/28/1990EP0399184A2 Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay
11/28/1990EP0399024A1 ANTI-INTERLEUKINE 1$g(a) AND 1$g(b) MONOCLONAL ANTIBODIES, METHOD FOR PRODUCING THE SAME AND APPLICATIONS OF SAID ANTIBODIES TO THE DETECTION OF INTERLEUKINES 1$g(a) AND 1$g(b) AND TO THERAPY
11/28/1990EP0398955A1 Diagnosis of retinoblastoma